Trials / Completed
CompletedNCT00347594
A Clinical Evaluation of the Next Generation Diagnostic Instrument (NGDI)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 76 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 21 Years – 75 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to measure the aberrations, corneal surface topography and pachymetry of normal human eyes with the NGDI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Next Generation Diagnostic Instrument (NGDI) | Measurement of the aberrations, corneal surface topography, and pachymetry of normal human eyes |
| DEVICE | Zyoptix Diagnostic Workstation (ZDW) | Measurement of the aberrations, corneal surface topography, and pachymetry of normal human eyes |
Timeline
- Start date
- 2005-08-01
- Primary completion
- 2006-09-01
- Completion
- 2006-09-01
- First posted
- 2006-07-04
- Last updated
- 2014-01-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00347594. Inclusion in this directory is not an endorsement.